Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1995 1
1996 4
1997 5
1998 3
1999 3
2000 7
2001 9
2002 11
2003 7
2004 6
2005 7
2006 6
2007 7
2008 9
2009 17
2010 7
2011 11
2012 11
2013 12
2014 16
2015 4
2016 7
2017 11
2018 20
2019 26
2020 29
2021 27
2022 19
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 30382327

279 results

Results by year

Filters applied: . Clear all
Page 1
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
Vitale LA, Thomas LJ, He LZ, O'Neill T, Widger J, Crocker A, Sundarapandiyan K, Storey JR, Forsberg EM, Weidlick J, Baronas AR, Gergel LE, Boyer JM, Sisson C, Goldstein J, Marsh HC Jr, Keler T. Vitale LA, et al. Cancer Immunol Immunother. 2019 Feb;68(2):233-245. doi: 10.1007/s00262-018-2267-0. Epub 2018 Oct 31. Cancer Immunol Immunother. 2019. PMID: 30382327
Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties.
Ceglia V, Zurawski S, Montes M, Bouteau A, Wang Z, Ellis J, Igyártó BZ, Lévy Y, Zurawski G. Ceglia V, et al. J Immunol. 2021 Oct 15;207(8):2060-2076. doi: 10.4049/jimmunol.2000704. Epub 2021 Sep 22. J Immunol. 2021. PMID: 34551965 Free PMC article.
Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Sadeghlar F, Vogt A, Mohr RU, Mahn R, van Beekum K, Kornek M, Weismüller TJ, Branchi V, Matthaei H, Toma M, Schmidt-Wolf IGH, Kalff JC, Strassburg CP, González-Carmona MA. Sadeghlar F, et al. Cancer Immunol Immunother. 2021 May;70(5):1451-1464. doi: 10.1007/s00262-020-02746-x. Epub 2020 Nov 12. Cancer Immunol Immunother. 2021. PMID: 33180184 Free PMC article.
279 results